Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients

Several reports described an increased risk of cardiovascular (CV) events, mainly atherothrombotic, in Chronic Myeloid Leukemia (CML) patients receiving nilotinib. However, the underlying mechanism remains elusive. The objective of the current cross-sectional retrospective study is to address a pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Bocchia, Monica, Galimberti, Sara, Aprile, Lara, Sicuranza, Anna, Gozzini, Antonella, Santilli, Francesca, Abruzzese, Elisabetta, Baratè, Claudia, Scappini, Barbara, Fontanelli, Giulia, Trawinska, Monika Malgorzata, Defina, Marzia, Gozzetti, Alessandro, Bosi, Alberto, Petrini, Mario, Puccetti, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342164/
https://www.ncbi.nlm.nih.gov/pubmed/27527867
http://dx.doi.org/10.18632/oncotarget.11100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342164/
https://www.ncbi.nlm.nih.gov/pubmed/27527867
http://dx.doi.org/10.18632/oncotarget.11100

Ejemplares similares